DE69519219D1 - Verwendung von (2S,4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazoline]-2-carboxamid zur Behandlung von Keratopathie - Google Patents

Verwendung von (2S,4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazoline]-2-carboxamid zur Behandlung von Keratopathie

Info

Publication number
DE69519219D1
DE69519219D1 DE69519219T DE69519219T DE69519219D1 DE 69519219 D1 DE69519219 D1 DE 69519219D1 DE 69519219 T DE69519219 T DE 69519219T DE 69519219 T DE69519219 T DE 69519219T DE 69519219 D1 DE69519219 D1 DE 69519219D1
Authority
DE
Germany
Prior art keywords
dioxospiro
keratopathy
chroman
imidazoline
carboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69519219T
Other languages
English (en)
Other versions
DE69519219T2 (de
Inventor
Kiichi Sawai
Masatoshi Ban
Makoto Sato
Chihiro Hibi
Kuniharu Mizuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Application granted granted Critical
Publication of DE69519219D1 publication Critical patent/DE69519219D1/de
Publication of DE69519219T2 publication Critical patent/DE69519219T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE1995619219 1994-12-28 1995-12-19 Verwendung von (2S,4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazoline]-2-carboxamid zur Behandlung von Keratopathie Expired - Fee Related DE69519219T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32759094 1994-12-28

Publications (2)

Publication Number Publication Date
DE69519219D1 true DE69519219D1 (de) 2000-11-30
DE69519219T2 DE69519219T2 (de) 2001-02-22

Family

ID=18200759

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1995619219 Expired - Fee Related DE69519219T2 (de) 1994-12-28 1995-12-19 Verwendung von (2S,4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazoline]-2-carboxamid zur Behandlung von Keratopathie

Country Status (2)

Country Link
EP (1) EP0719556B1 (de)
DE (1) DE69519219T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0909558A3 (de) * 1997-08-29 1999-10-27 Santen Pharmaceutical Co., Ltd. Ophthalmische Lösung enthaltend ein Chromanderivat
JP4014053B2 (ja) 2004-01-30 2007-11-28 株式会社三和化学研究所 糖尿病黄斑症の予防又は治療剤
WO2008052126A2 (en) * 2006-10-25 2008-05-02 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Ointment comprising phosphatidylserine as active agent for cancer treatment
CN103222974A (zh) 2007-01-31 2013-07-31 株式会社三和化学研究所 视网膜神经或视神经的保护剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3769066D1 (de) * 1986-08-28 1991-05-08 Sanwa Kagaku Kenkyusho Co Hydantoin-derivate zur behandlung von komplikationen bei diabetes.
US4900739A (en) * 1988-10-20 1990-02-13 American Home Products Corp. Novel spirosuccinimides as aldose reductase inhibitors and antihyperglycemic agents
JPH03215435A (ja) * 1990-01-12 1991-09-20 Sanwa Kagaku Kenkyusho Co Ltd アルドース還元酵素阻害剤を主成分とする潰瘍治療剤
JP2997894B2 (ja) * 1990-11-07 2000-01-11 株式会社三和化学研究所 循環器系疾患の予防及び治療剤

Also Published As

Publication number Publication date
EP0719556B1 (de) 2000-10-25
DE69519219T2 (de) 2001-02-22
EP0719556A3 (de) 1997-02-26
EP0719556A2 (de) 1996-07-03

Similar Documents

Publication Publication Date Title
ATE175198T1 (de) N-acylierte trizyklische azaheteroringe verwendbar als vasopressin-antagonisten
ATE224189T1 (de) Antikonvulsive sulfamatderivate zur behandlung von fettleibigkeit
DE59711321D1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
NO944406D0 (no) Nye 7 se inhibitorer
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
DE69434777D1 (de) Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln
DE69504949T3 (de) Verwendung eines Antagonisten der Substanz P zur Behandlung von Hautrötungen neurogen Ursprungs
ATE264309T1 (de) Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren
DE69519219D1 (de) Verwendung von (2S,4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazoline]-2-carboxamid zur Behandlung von Keratopathie
DE59508900D1 (de) Verwendung von Dibrom-thiophen-carbonsäure-Derivaten als Mikrobizide
DE69408394T2 (de) 4-Piperidino-piperidin zur Behandlung von Tumoren
DE69412178T2 (de) Apparat zur Behandlung von Lagen
ATE204167T1 (de) Antikonvulsive derivate zur behandlung von psoriasis
DE69616760D1 (de) Verwendung von 4-tert-butyl-1-cyclohexanol als antioxidant
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
DE69926996D1 (de) Verwendung von riluzol zur behandlung der retinalischemie
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
DE59914948D1 (de) Verwendung von 1-(aminoalkyl)-3-chinoxalin-2-on-derivaten zur herstellung von als antioxidantien wirkenden zusammensetzungen
DE69819503D1 (de) Verwendung von 7-apha-methyl-17-alpha-ethynyl-estrane derivaten zur behandlung von atherosclerose
DE69302250D1 (de) Verwendung von Isoquinolinon-Derivaten zur Behandlung von Hyperlipoproteinemia
DE69711422D1 (de) Verwendung von (r)-verapamil als medizin zur behandlung von angina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee